Cargando…

Quantitative imaging to evaluate malignant potential of IPMNs

OBJECTIVE: To investigate using quantitative imaging to assess the malignant potential of intraductal papillary mucinous neoplasms (IPMNs) in the pancreas. BACKGROUND: Pancreatic cysts are identified in over 2% of the population and a subset of these, including intraductal papillary mucinous neoplas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanania, Alexander N., Bantis, Leonidas E., Feng, Ziding, Wang, Huamin, Tamm, Eric P., Katz, Matthew H., Maitra, Anirban, Koay, Eugene J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349873/ https://www.ncbi.nlm.nih.gov/pubmed/27588410 http://dx.doi.org/10.18632/oncotarget.11769

Ejemplares similares

Imaging of IPMN of the pancreas: evaluation of malignant potential and resectability
por: Lee, Jeong Min
Publicado: (2015)

Survival Outcomes of Pancreatic Intraepithelial Neoplasm (PanIN) versus Intraductal Papillary Mucinous Neoplasm (IPMN) Associated Pancreatic Adenocarcinoma
por: McGinnis, Timothy, et al.
Publicado: (2020)

Evaluating IPMN and pancreatic carcinoma utilizing quantitative histopathology
por: Glazer, Evan S., et al.
Publicado: (2016)

Humoral Predictors of Malignancy in IPMN: A Review of the Literature
por: Nista, Enrico C., et al.
Publicado: (2021)

Do molecular tests really differentiate malignant IPMNS from benign?
por: Basar, Omer, et al.
Publicado: (2016)

State-of-the-art surgical treatment of IPMNs
por: Salvia, Roberto, et al.
Publicado: (2021)

Total Pancreatectomy for Malignant Intraductal Papillary Mucinous Neoplasm (IPMN) Complicated by Gastropancreatic Fistulae
por: Basnayake, Oshan, et al.
Publicado: (2020)

RNF43 Mutations in IPMN Cases: A Potential Prognostic Factor
por: Chang, Xiao Yan, et al.
Publicado: (2020)

Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study
por: Zaid, Mohamed, et al.
Publicado: (2020)

Association of Chronic Pancreatitis and Malignant Main Duct IPMN: A Rare but Difficult Clinical Problem
por: Berger, Zoltán, et al.
Publicado: (2017)

PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer
por: Douglas, Julia E., et al.
Publicado: (2022)

Reappraisal of the Immunophenotype of Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs)—Gastric Pyloric and Small Intestinal Immunophenotype Expression in Gastric and Intestinal Type IPMNs—
por: Kobayashi, Mikiko, et al.
Publicado: (2014)

EZH2 Is Associated with Malignant Behavior in Pancreatic IPMN via p27(Kip1) Downregulation
por: Kuroki, Hideyuki, et al.
Publicado: (2014)

CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
por: Tobaly, David, et al.
Publicado: (2020)

What Is the Best Way to Identify Malignant Transformation Within Pancreatic IPMN: A Systematic Review and Meta-Analyses
por: Sultana, Asma, et al.
Publicado: (2015)

Co-occurrence of IPMN and malignant IPNB complicated by a pancreatobiliary fistula: A case report and review of the literature
por: Ren, Xu, et al.
Publicado: (2019)

Precursor Lesions for Sporadic Pancreatic Cancer: PanIN, IPMN, and MCN
por: Distler, M., et al.
Publicado: (2014)

Characterization and management of cystic pancreatic neoplasms communicating lesions (IPMN)
por: Morana, Giovanni, et al.
Publicado: (2014)

Invasive carcinoma derived from branch duct-type IPMN may be a more aggressive neoplasm than that derived from main duct-type IPMN
por: OKABAYASHI, TAKEHIRO, et al.
Publicado: (2013)

Use of Autoreactive Antibodies in Blood of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMN) for Grade Distinction and Detection of Malignancy
por: Brindl, Niall, et al.
Publicado: (2022)

Extent of Surgery and Implications of Transection Margin Status after Resection of IPMNs
por: Paini, Marina, et al.
Publicado: (2014)

Extensive multifocal branch duct IPMN of the pancreas after liver transplantation: is surgery justified?
por: Branchi, Vittorio, et al.
Publicado: (2015)

Supplemental (18)F-FDG-PET/CT for Detection of Malignant Transformation of IPMN—A Model-Based Cost-Effectiveness Analysis
por: Bicu, Felix, et al.
Publicado: (2021)

Spontaneous gastro-pancreatic fistula – a hitherto unknown natural history of IPMN?
por: Rao, V, et al.
Publicado: (2012)

The Clinical and Socio-Economic Relevance of Increased IPMN Detection Rates and Management Choices
por: Budde, Christoph, et al.
Publicado: (2015)

Limitations and prospects in the management of IPMN: a retrospective, single-center observational study
por: Peisl, Sarah, et al.
Publicado: (2023)

SDC1 and ITGA2 as novel prognostic biomarkers for PDAC related to IPMN
por: Zhang, Chuan-long, et al.
Publicado: (2023)

Erratum to: Extensive multifocal branch duct IPMN of the pancreas after liver transplantation: is surgery justified?
por: Branchi, Vittorio, et al.
Publicado: (2015)

Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy
por: Liang, Tom Z., et al.
Publicado: (2023)

Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria?
por: Pozzi Mucelli, Raffaella M., et al.
Publicado: (2022)

Intraductal papillary mucinous neoplasm of the pancreas (IPMN): clinico-pathological correlations and surgical indications
por: Baiocchi, Gian Luca, et al.
Publicado: (2010)

Imaging of the Pancreas in New-Onset Diabetes: A Prospective Pilot Study
por: Wu, Bechien U., et al.
Publicado: (2022)

Imaging‐based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy
por: Amer, Ahmed M., et al.
Publicado: (2018)

External validation of nomogram for predicting malignant intraductal papillary mucinous neoplasm (IPMN): from the theory to the clinical practice using the decision curve analysis model
por: Casadei, Riccardo, et al.
Publicado: (2021)

BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation
por: Hennig, R, et al.
Publicado: (2008)

Prognostic influence of endoscopic ultrasound-guided fine needle aspiration in IPMN-derived invasive adenocarcinoma
por: Suzuki, Rei, et al.
Publicado: (2018)

Branch Duct – IPMN and PanIN, in IgG4‐Autoimmune pancreatitis: A case report
por: Lazzarin, Gianni, et al.
Publicado: (2020)

Telemedicine and IPMN: Analysis of a new follow-up strategy during COVID-19 outbreak
por: Farguell, J., et al.
Publicado: (2022)

Blood-Based Diagnosis and Risk Stratification of Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN)
por: Zhang, Chaoyang, et al.
Publicado: (2023)

Unconventional treatment of inoperable biliary IPMN with an oesophageal stent in the common bile duct: case report
por: Siiki, Antti, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s2334q3lr0e32026nlg3u72ecs